中医药联合多巴制剂治疗帕金森病的临床研究进展  被引量:11

Clinical Research Progress in Traditional Chinese Medicines Combined with Dopa Preparations in the Treatment of Parkinson's Disease

在线阅读下载全文

作  者:王贤正[1] 钱梦[1] 谢鸣[1] Wang Xianzheng Qian Meng Xie Ming(Department of Formulaology, Beijing University of Chinese Medicine, Beijing 100029, China)

机构地区:[1]北京中医药大学方剂学系,北京100029

出  处:《中国药师》2017年第9期1578-1583,共6页China Pharmacist

摘  要:多巴制剂是目前临床上治疗帕金森病的首选药物。随着多巴制剂应用时间的延长和用量的加大,其治疗作用越来越小,不良反应反而越来越大,已成为影响其临床应用的主要问题。研究表明,中医药与多巴制剂联合应用具有提高疗效、减少西药的用量及减轻其不良反应等作用。本文就近十年来多巴制剂联合中医药治疗帕金森病的进展进行评述。Dopa preparations are currently first choice for the clinical treatment of Parkinson ' s disease. With the application time extension and the dose increase of dopa preparations, the therapeutic effect is smaller and smaller, while the side effects are more and more significant, which have become the main problems affecting their clinical application. The current researches showed that the combination of traditional Chinese medicines and dopa preparations can improve the efficacy, decrease the dose of western medicines, reduce the adverse effects and so on. The paper reviewed the progress in the combination of dopa preparations and traditional Chinese medicines in the treatment of Parkinson' s disease in recent ten years.

关 键 词:中医药 多巴制剂 帕金森病 增效减毒 

分 类 号:R277.7[医药卫生—中医学] R286

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象